By Nascent Biotech Posted April 4, 2018 In HAH 2018 2pp CFP Leaflet copy2018-04-042018-04-04http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttp://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.png200px200px 0 Recent PostsNascent Biotech Regains Worldwide Rights for PritumumabNBIO Link Report for May 10, 2023Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual MeetingA Letter to Nascent Biotech Shareholders, May 1, 2023